Alvotech secures $100 million term loan facility
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Alvotech Secures Term Loan Facility of USD 100 Million
December 31, 2025 4:30 PM ESTUSD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotechs R&D pipeline and global product launches through 2026Led by GoldenTree Asset Management
REYKJAVIK, ICELAND (December 31, 2025) Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity... More
